How to Tell if the Pipeline Is Weak

The dashboard says 3.4x coverage. Green tick, no flags. The VP closes the laptop and tells the board pipeline is healthy.

Eleven weeks later the quarter comes in at 61% of target, and nobody can explain how a "healthy" pipeline produced a bad number. Here's how: coverage was never measuring the pipeline. It was measuring how comfortable everyone felt not looking closer.

That's the part nobody says in the Monday pipeline review. The ratio on the screen isn't a diagnosis. It's a number chosen, almost always without anyone noticing, to make the room stop asking questions.

The 3x rule was borrowed, not earned

Ask a sales leader why they use 3x coverage and you'll get a shrug. "It's the standard." It isn't. It's a rearrangement of one piece of maths: required coverage equals 1 divided by your win rate. A 25% win rate needs 4x coverage to hit plan reliably. A 20% win rate needs 5x. Only a 50% win rate — rare outside the smallest, warmest deals — gets away with 2x. Plenty of ordinary B2B teams sit in the 15% to 25% band, the same range research on enterprise coverage puts at needing 4x to 7x, not the 3x everyone quotes like scripture.

So why does 3x survive? Because nobody wants to run the other side of that equation: their actual, trailing, closed-won win rate. That number requires pulling twelve months of real outcomes, not the win rate a rep remembers from the two deals they're proud of. A rep who "feels" like they close a quarter of what they touch is often closer to a fifth, once you count the deals that quietly died instead of formally lost.

Here's what that gap costs. A $900,000 pipeline against a $300,000 quota looks like 3x — safe, by the industry rule of thumb. Recalculate it against an actual trailing win rate of 18%, and the required coverage is 5.5x. That rep isn't covered. They're short by roughly $750,000 in real terms, and the dashboard told them the opposite for an entire quarter.

Nobody catches this because nobody wants to be the one who reruns the maths and finds their own number is wrong. The multiplier stays generic because a generic multiplier never accuses anyone of anything.

Coverage counts deals. It doesn't count truth.

A pipeline can hold its ratio while quietly rotting from the inside, because coverage treats every open deal as equal weight, regardless of whether it's alive.

The 2023 B2B Sales Benchmark Report, built from 3.2 million opportunities and $37 billion in pipeline across 364 companies, found average win rates fell 15% year over year and sales cycles stretched 32% longer in the same period. More strikingly: 37% of deals slipped their close date that year, up 21% on the year before, and 68% of close dates were set earlier than what the data called the "golden period" — the window in which a deal actually has the best odds of closing.

Read that carefully. Reps and their managers are systematically guessing close dates too early, then re-forecasting, then re-forecasting again — and every one of those slipping deals still sat in the coverage count the whole time, propping up a ratio that looked fine on the screen while quietly telling nobody the truth about timing.

This is stage leakage, and it's invisible to a single coverage number because coverage doesn't ask which stage a deal is stuck in or how long it's been stuck there. Pull your own stage-to-stage conversion — the percentage of deals that actually move from stage two to stage three, not the percentage that get manually nudged forward to look active — and you'll usually find one transition bleeding out more deals than the rest combined. That's where the pipeline is actually weak. The overall ratio just isn't built to show you.

Activity is not the same as progress

CRMs make it easy to confuse the two, because a stage change and a genuine step forward look identical on a report. A rep drags a card from "discovery" to "proposal" because the pipeline review is Thursday and an untouched deal invites questions nobody wants to answer that day. Nothing about the buyer's situation changed. The label did.

That single move does real damage to your coverage number, because it re-weights a cold deal as a warmer one without a shred of new evidence. Multiply it across a team of eight reps, each doing it two or three times a quarter to survive a review unscathed, and you've built a pipeline that looks like it's accelerating while the underlying deals are exactly where they were a month ago. The 68% figure above isn't really about calendars. It's about a team that would rather move a date than say a deal has stalled.

The tell is simple, and it takes one query to find: pull every deal that changed stage in the last 30 days and check how many also had a genuine new artefact attached — a call, an email exchange, a new stakeholder, a document sent. If the stage moved and nothing else did, that's not progress. That's a rep managing the report, not the deal.

The volume you're proud of might be the problem

Here's the angle almost nobody wants to hear from their own funnel: the fastest way to fix a bad coverage ratio is to add more leads, and adding more leads is very often exactly the wrong move.

Salesforce, citing MarketingSherpa's research, has long put the number at 79% — the share of marketing leads that never convert into a sale, mostly from poor nurturing and weak qualification. Separate data from InsideSales.com found 51% of leads are never contacted by anyone at all. Average MQL-to-SQL conversion sits at just 13% across industries; teams using real behavioural qualification triple that, to around 40%. Fully 84% of B2B businesses call MQL-to-SQL conversion one of their hardest problems to solve.

Now put those numbers next to what actually predicts a win. The same 2023 benchmark report found opportunities with genuinely high buyer engagement won at a rate 340% better than average-engagement deals, and deals where the rep fully used a real qualification framework closed 311% more often than deals that didn't. Engagement and qualification move the needle by triple digits. Raw volume barely moves it at all.

So when a coverage ratio dips, the reflex is to ask marketing for more leads. That reflex fixes the number on the screen and does nothing for the business, because most of what gets added lands in the 79% that never converts anyway. It just gives everyone a bigger, sadder pile of the same problem, dressed up as progress.

The uncomfortable question is rarely asked out loud: are we chasing volume because we believe it works, or because a bigger pipeline number is easier to defend in a leadership meeting than admitting our targeting is off?

What a weak pipeline actually looks like, up close

I've seen a $2 million pipeline sit at a "healthy" 3.6x coverage while over half the open deals hadn't had a single logged touch in more than 30 days. The team's quoted win rate was "around 28%, maybe a bit more." The real number, pulled from twelve months of closed opportunities, was 14%. Half the deals were quietly dead. The other half were being asked to cover a target they were mathematically never going to reach, because the coverage math was built on a win rate nobody had checked in over a year.

Nobody had lied, exactly. They'd just never looked. Looking meant admitting the number the board had been shown all year was never real.

Five questions worth asking this week

Pull your last twelve months of closed-won and closed-lost deals and calculate your actual win rate. Not the one anyone remembers — the one the data says.

Recalculate your required coverage using that real number, and compare it to whatever multiplier you're currently using to feel comfortable.

Find your stage-to-stage conversion rates and identify the single worst transition. That's your leak, not the average.

Check what share of current pipeline came from a genuinely qualified conversation versus a name pulled from a list or an inbound form nobody screened.

Check the age of every open deal against your own historical close window, not an industry average, and flag anything that's overstayed it.

None of these take new software. They take an afternoon and a willingness to find out your number was wrong.

The part nobody says

A coverage ratio isn't a measurement of your pipeline. It's a measurement of how much your organisation has agreed not to ask. It exists, in most businesses, to end the discomfort of not knowing — one clean number that lets everyone stop looking and go back to their day.

If your pipeline number has made you feel calm every single week for the past year, that isn't evidence it's healthy. It's evidence nobody has stress-tested it. A ratio that never makes you uncomfortable isn't checking anything. It's just agreeing with you.

If you want a genuine read on whether your pipeline is covered or just counted, that's exactly what a proper sales audit checks — alongside the reasons targets get missed in the first place. See how we run that audit, or talk to us before your next quarter starts.